Sort
34,240 grants matching “atherosclerosis”
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS
$710,152Devendra K. Agrawal · Creighton University · R01 · FY2016 · HL
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS
$710,152Devendra K. Agrawal · Creighton University · R01 · FY2017 · HL
Comprehensive Magnetic Resonance in PAD
$710,028Christopher M Kramer · University Of Virginia · R01 · FY2014 · HL
Developmental stuttering: Population-based genetic discovery
$709,983Jennifer Below · Vanderbilt University Medical Center · R01 · FY2019 · DC
Genomic approaches to cardiometabolic risk and treatment in HIV
$709,888Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · HL
Unraveling the cell divergent roles of Glucocorticoid-Induced TNF-R Related Protein (GITR): A new opportunity to treat atherosclerosis using targeted immunotherapy
$709,869Esther Lutgens · Mayo Clinic Rochester · R01 · FY2025 · HL
The Role of Histone Deacetylase 9 in Vascular Calcification
$709,806Rajeev Malhotra · Massachusetts General Hospital · R01 · FY2018 · HL
Gene Expression and Thrombosis in a Community Based Cohort Study
$709,795Jane E Freedman · Boston University Medical Campus · R01 · FY2008 · HL
Human Studies on Blood Levels of Glycated CD59 as a Biomarker in Diabetes
$709,715Jose A Halperin · Brigham And Women'S Hospital · R01 · FY2014 · DK
Sleep Apnea in TIA: Reducing Cardiovascular Risk with Positive Airway Pressure
$709,704Henry Klar Yaggi · Yale University · U34 · FY2011 · HL
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis
$709,682Athan Kuliopulos · Tufts Medical Center · R01 · FY2020 · HL
Matrix Metalloprotease-PAR1 Regulation of Atherosclerosis
$709,682Athan Kuliopulos · Tufts Medical Center · R01 · FY2019 · HL
Gene Therapy in Hutchinson-Gilford Progeria Syndrome
$709,670Jonathan David Brown · Vanderbilt University Medical Center · R01 · FY2024 · HL
Blood Markers of Vulnerability in High Risk Vascular Patients
$709,640Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2011 · HL
Blood Markers of Vulnerability in High Risk Vascular Patients
$709,566Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2012 · HL
Improving CBF through direct control of CSF pulsations
$709,536Mark Gregory Luciano · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · NS
Postdoctoral Training in Cardiovascular Disease
$709,493Mark A Hardy · Columbia University Health Sciences · T32 · FY2017 · HL
Platelets in Cardiovascular Biology and Pathology
$709,459Denisa D Wagner · Massachusetts Institute Of Technology · P01 · FY2010 · HL
The Role of Arylsulfatase in Vascular Calcification
$709,203Rajeev Malhotra · Massachusetts General Hospital · R01 · FY2023 · HL
Genetic Predisposition to Myocardial Infarction in Patients with Coronary Artery Disease
$709,076Hooman Allayee · University Of California Los Angeles · R01 · FY2025 · HL
Gut flora metabolism of dietary phosphatidylcholine and cardiovascular disease
$709,072Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Pathophysiology of Myocardial Disease
$709,059David Alan Kass · Johns Hopkins University · T32 · FY2009 · HL
Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease
$709,024Reza Shekarriz · Exhalix, Llc · R44 · FY2019 · HL
Coronary Atherosclerosis Evaluation by Arterial Wall MRI
$709,022David A. Bluemke · Johns Hopkins University · R01 · FY2006 · HL
Psycho-neuro-immune Mechanisms Linking Stigma and Discrimination to Carotid Plaque Formation in Persons living with HIV
$708,908Roger Christopher McIntosh · University Of Miami Coral Gables · R01 · FY2023 · HL